GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Vimab Group AB (FRA:NM4) » Definitions » EV-to-FCF

Vimab Group AB (FRA:NM4) EV-to-FCF

: 10.37 (As of Today)
View and export this data going back to 2023. Start your Free Trial

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Vimab Group AB's Enterprise Value is €25.80 Mil. Vimab Group AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was €2.49 Mil. Therefore, Vimab Group AB's EV-to-FCF for today is 10.37.

The historical rank and industry rank for Vimab Group AB's EV-to-FCF or its related term are showing as below:

FRA:NM4' s EV-to-FCF Range Over the Past 10 Years
Min: -90.52   Med: 8.71   Max: 59.37
Current: 10.18

During the past 12 years, the highest EV-to-FCF of Vimab Group AB was 59.37. The lowest was -90.52. And the median was 8.71.

FRA:NM4's EV-to-FCF is ranked better than
64.4% of 705 companies
in the Business Services industry
Industry Median: 13.82 vs FRA:NM4: 10.18

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-16), Vimab Group AB's stock price is €0.818. Vimab Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.032. Therefore, Vimab Group AB's PE Ratio for today is At Loss.


Vimab Group AB EV-to-FCF Historical Data

The historical data trend for Vimab Group AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimab Group AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-FCF
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.75 -106.22 1.90 -13.99 -155.86

Vimab Group AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-FCF Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.44 -155.86 11.39 12.70 8.60

Competitive Comparison

For the Consulting Services subindustry, Vimab Group AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimab Group AB EV-to-FCF Distribution

For the Business Services industry and Industrials sector, Vimab Group AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Vimab Group AB's EV-to-FCF falls into.



Vimab Group AB EV-to-FCF Calculation

Vimab Group AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=25.797/2.488
=10.37

Vimab Group AB's current Enterprise Value is €25.80 Mil.
Vimab Group AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vimab Group AB  (FRA:NM4) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Vimab Group AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.818/-0.032
=At Loss

Vimab Group AB's share price for today is €0.818.
Vimab Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.032.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Vimab Group AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Vimab Group AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Vimab Group AB (FRA:NM4) Business Description

Traded in Other Exchanges
Address
Malmskillnadsgatan 40A, Stockholm, SWE, 111 57
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.

Vimab Group AB (FRA:NM4) Headlines

No Headlines